Participants in a Drug Enforcement Administration (DEA) hearing on the Trump administration’s marijuana rescheduling proposal have filed their final briefs in the proceedings—setting up the judge overseeing the matter to issue his recommendation on the reform. DEA, which is charged with defending the proposed move of cannabis from Schedule I of the Controlled Substances Act (CSA)…...
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
